The Cato Institute held a discussion on the rise of synthetic or “designer” drugs. The panelists focused on strategies to address consumer demand.
People in this video
Ted Galen Carpenter Senior Fellow Cato Institute
Jacob G Hornberger Founder and President Future of Freedom Foundation
Christopher A. Preble Vice President Cato Institute->Defense and Foreign Policy Studies
Eric Sterling President Criminal Justice Policy Foundation
- Cato InstituteCato Institute
U.S. Drug Policy
Panelists talked about U.S. drug policy at home and abroad. Michael Botticelli, acting director of the White House Office of…
David Mitchell on Prescription Drug Costs
David Mitchell talked about efforts by his Patients For Affordable Drugs organization to lower prescription drug prices.
Prescription Drug Prices
Senator Susan Collins (R-ME), who chairs the Senate Special Committee on Aging, delivered a speech at the Pew…
President Trump on Drug Pricing
President Trump visited the Health and Human Services Department to announce changes to Medicare prescription drug…